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REVIEW ARTICLE OPEN
Raman spectroscopy and regenerative medicine: a review
Katherine J. I. Ember1,2, Marieke A. Hoeve2, Sarah L. McAughtrie1, Mads S. Bergholt4,5,6, Benjamin J. Dwyer2, Molly M. Stevens4,5,6,
Karen Faulds3, Stuart J. Forbes2 and Colin J. Campbell1
The field of regenerative medicine spans a wide area of the biomedical landscape—from single cell culture in laboratories to
human whole-organ transplantation. To ensure that research is transferrable from bench to bedside, it is critical that we are able to
assess regenerative processes in cells, tissues, organs and patients at a biochemical level. Regeneration relies on a large number of
biological factors, which can be perturbed using conventional bioanalytical techniques. A versatile, non-invasive, non-destructive
technique for biochemical analysis would be invaluable for the study of regeneration; and Raman spectroscopy is a potential
solution. Raman spectroscopy is an analytical method by which chemical data are obtained through the inelastic scattering of light.
Since its discovery in the 1920s, physicists and chemists have used Raman scattering to investigate the chemical composition of a
vast range of both liquid and solid materials. However, only in the last two decades has this form of spectroscopy been employed in
biomedical research. Particularly relevant to regenerative medicine are recent studies illustrating its ability to characterise and
discriminate between healthy and disease states in cells, tissue biopsies and in patients. This review will briefly outline the principles
behind Raman spectroscopy and its variants, describe key examples of its applications to biomedicine, and consider areas of
regenerative medicine that would benefit from this non-invasive bioanalytical tool.
npj Regenerative Medicine  (2017) 2:12 ; doi:10.1038/s41536-017-0014-3
INTRODUCTION
Chronic diseases—a worldwide problem
Biomedical research into stem cells and tissue regeneration has
brought about effective therapies for chronic diseases, notably
bone marrow and whole organ transplantation.1 However, the aim
is now to reduce the necessity for organ transplantation as it has
severe limitations; such as organ availability and quality, the need
for major surgery, and lifelong use of immunosuppressive drugs.1, 2
Regenerative medicine aims to develop new techniques to grow
cells and tissues in vitro for transplantation, and to stimulate tissue
regeneration in vivo. Non-invasively assessing healthy, regenerat-
ing and diseased tissues will be critical for the field. The
assessment of tissue structure can be performed using conven-
tional imaging modalities such as ultrasound, computed tomo-
graphy (CT) and magnetic resonance imaging (MRI). However, the
assessment of tissue function remains a challenge. Raman
spectroscopy (hereafter also referred to as “Raman”) offers the
capacity to biochemically assess cell and tissue function in a label-
free and non-destructive manner. This review will address
applications of Raman spectroscopy to regenerative medicine—
in addition to providing a summary of the basic physical
principles, the current state of technology and the advantages
over existing methods.
Biomedical research—a need for new techniques
Studying the underlying mechanisms of tissue regeneration is
critical. However, many current analytical techniques involve
disrupting the very processes under investigation (for example,
tissue sectioning and immunostaining). There is a growing need
for a non-destructive, non-invasive technique capable of analysing
samples at a biomolecular level,3 in primary research, disease
diagnosis and the monitoring of repair.4 Raman spectroscopy is
established as a powerful laboratory technique and recent in vivo
clinical trials indicate its potential for biomolecular characterisa-
tion and diagnostics. Furthermore, this spectroscopic tool could
also become an invaluable tool for regenerative medicine.5, 6
Raman spectroscopy is a non-destructive, label-free technique
used to determine the molecular composition of samples in a variety
of states. It uses laser light to discriminate between different cell and
tissue types, and has shown great promise in in vivo diagnosis, with
the potential to eliminate or reduce the need for biopsies.7 Raman
could prove particularly crucial in diagnosing diseases early in their
pathogenesis, as it can detect chemical alterations before morpho-
logical changes are evident. Cellular differentiation,8, 9 mitosis10, 11
and apoptosis12, 13 all instigate molecular changes that can be
detected via Raman, and it could be used to assess the effects of
post-transplant organ regeneration,14, 15 as well as the efficacy of
therapeutic interventions.
RAMAN SPECTROSCOPY
The principles of Raman spectroscopy
Spectroscopy is used to study the interactions of radiation
(including electromagnetic radiation) with matter and is a field
that encompasses a wide range of techniques. Raman spectro-
scopy employs the inelastic scattering of light by matter; this
“Raman” scattering was initially predicted by Adolf Smekal in 1923
and first observed by C.V. Raman in 1928.16, 17
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When a photon of light interacts with a molecule, it can induce
a short-lived transition to a virtual energy state (Fig. 1). This
temporary increase in energy means that the molecule is in a
higher or virtual energy state. The molecule can relax back to the
initial ground state in a single step by releasing the same amount
of energy as that of the incoming photon—this processis known
as Rayleigh (or elastic) scattering. As the energy of a photon is
proportional to its frequency, and since no energy is transferred to
the molecule, Rayleigh scattered light does not yield any
information about the molecules under investigation.18
However, relaxation can also occur in an inelastic manner—
when a molecule releases a different quantity of energy to that of
the incident photon. This phenomenon is known as Raman
scattering; due to nuclear motion, energy can be transferred to or
from the incident photon. There are two types of Raman
scattering—Stokes and anti-Stokes scattering. In the case of
Stokes scattering, energy can be transferred to the molecule from
the incident photon via nuclear motion within the molecule,
resulting in a scattered photon of reduced energy and hence
reduced frequency. Conversely, in a smaller proportion of
molecules energy is transferred to the photon as, due to the
distribution of thermal energy, these molecules are initially in a
higher energy state. This is anti-Stokes scattering.18, 19 In
biomedical research, Stokes scattering is most commonly
observed and the signal is inherently weak. Only 1 in ∼108
photons undergo Raman scattering.
To elicit Raman scattering, a laser is used to provide coherent,
monochromatic light for excitation of molecules. A diffractive
spectrometer based on a reflective or holographic grating is then
used to disperse the light onto highly sensitive detectors such as
cooled charge-coupled devices to generate a spectrum.18, 20 A
simplified schematic of a Raman spectroscopy system is shown in
Fig. 2a.
A typical Raman spectrum is a plot of intensity of the scattered
light in wavenumbers (a variable which is proportional to
frequency) relative to the incident laser excitation. Specific
molecular bonds vibrate at particular wavenumbers (Fig. 2b) and
each molecule will have a characteristic spectroscopic fingerprint.
As intensity of the Raman spectrum is related to the concentration
of the molecules (scaling linearly with the concentration of the
molecules in transparent samples), interpretation of Raman
spectra can be used to infer the chemical composition of a
sample. Raman can be applied to a variety of sample types,
including solids and solutions and often no sample preparation is
Fig. 1 "Jablonski" style diagram of energetic transitions involved in Raman scattering. Rayleigh scattering is elastic; the incident photon is of
the same energy as the scattered photon. Raman scattering is inelastic; in Stokes scattering, the incident photon is of greater energy than the
scattered photon, while in anti-Stokes scattering, the incident photon is of lower energy
Fig. 2 a Schematic diagram of a Raman spectrometer adapted from
Butler et al.20 (Permission obtained from Nature Publishing Group).
Excitation light is represented by a blue line, while the green line
represents scattered light. Excitation light travels from the laser source,
through narrow band pass filters, beam expander and a dichroic mirror.
It is then reflected off a mirror into a system of optics where it is
directed onto the sample. Light scattered from the sample is collected
by the optics and is directed by focusing mirror and long pass filters
onto a grating through which it is dispersed. This dispersed light is
finally focused onto the detector. b Raman spectrum of phenylalanine
crystals using a 532 nm laser at 30mW power and 1 s exposure using a
50× air objective. Spectral resolution of the system is 0.5 cm−1
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required. Acquisition of a single spectrum is rapid—an individual
Raman spectrum can be obtained within 0.1–10 s, depending on
the sensitivity of the specific system.
Raman techniques
A number of Raman techniques have been developed, each with
its own set of advantages and disadvantages. This toolbox of
Raman techniques, each applicable to a different set of biological
problems, is summarised in Table 1.
Raman microspectroscopy. In biomedical analyses, Raman spec-
troscopy is especially powerful when combined with light
microscopy to yield a composite image that combines molecular
and morphological information. A single spectrum can be
obtained from volumes smaller than 1 μm3 (ref. 21). By raster
scanning a sample using a motorised or piezo stage, a
hyperspectral Raman image can be generated with biochemical
contrast and very high spatial resolution (Fig. 3).
These microspectroscopy techniques can give information
about the properties of heterogeneous samples such as tissue
and could be used as non-invasive, non-destructive alternatives to
histology (i.e., spectral histopathology). Raman microspectroscopy
has been used to assess the distribution of components,22 detect
molecular gradients and discriminate between cell types.23, 24
Resonance Raman spectroscopy (RRS). One limitation of Raman
spectroscopy is the relatively low signal intensity. This can be
overcome using RRS. Selection of a laser excitation wavelength
corresponding to the electronic absorption maximum of a
particular chemical25 (for example 530.9 nm will excite cyto-
chromes)26 enhances the Raman signal of particular bands by a
factor of 103–105 (ref. 18). This has been used to extensively study
haemoglobin and observe cytochrome-c release from mitochon-
dria during apoptosis.27
Surface enhanced Raman spectroscopy (SERS). SERS employs
metal nanoparticles (or a roughened metal surface) to increase
the Raman signal by a factor of 106 (ref. 19). This happens because
the delocalised electrons at a metal surface exist as an oscillating
surface plasmon, which in turn generates an associated electric
field at the metal surface. This significantly increases the Raman
signal for any molecules close to the metal surface.28–30 RRS can
be coupled with SERS to further enhance the signal in a method
known as SERRS.
By incorporating nanoparticles into a biological system, SERS
can be used to increase the signal- to-noise ratio. Although silver
nanoparticles give the largest enhancement, gold is significantly
more biocompatible and is often the metal of choice in biological
studies.31, 32 Recent biomedical studies have made use of
functionalised nanoparticles—particles with molecules attached
to the surface that can yield information about the system
indirectly. For example, gold nanoparticles have been functiona-
lised with molecules which produce Raman spectra that are
sensitive to the redox state or pH of the environment, thus
allowing pH or redox changes associated with disease to be
assessed.33, 34
SERS is not without its challenges; one of the key hurdles being
delivery of nanoparticles in a way that does not perturb the
biological system.35 However, by mounting a sample on a metal-
coated slide, enhancement can be achieved without nanoparti-
cles, and this technique has been used to create biosensors
capable of quantifying the concentrations of metabolites (e.g.,
glucose) within biofluid samples.36 Techniques are also under
development to combine SERS with optical fibres to make
measurements of pH associated with lung disease.37, 38
Spatially offset Raman spectroscopy (SORS). The depth at which
many optical techniques can be used is limited by the extent to
which light can penetrate through tissue. SORS is a variant of
Raman spectroscopy that is able to achieve collection from deep
within tissue by measuring diffuse Raman scattering from a region
away from the laser excitation. Using this technique, it has
been possible to obtain signals from depths of 40 mm (refs 39, 40).
A SORS-based technique is under development for detection of
breast tumours using optical fibres.41 Esmonde-White et al.42
constructed a Raman tomographic technique based on the same
principle.
SESORS (surface-enhanced SORS) combines SORS with SERS
nanoparticles. Xie et al.43 successfully tracked biophosphonate-
functionalised SERS nanoparticles to a depth of 20 mm in
porcine tissue and, using this technique, they were able to
construct a false-colour image of the distribution of these
particles within the tissue. Having surpassed the depth
limitations of conventional Raman spectroscopy, further devel-
opment of these techniques may enable probing of sub-surface
disease states and drug distribution. For example, SERRS
nanoparticles conjugated to antibodies against certain biomar-
kers could potentially detect disease features such as tumours
Table 1. Summary of Raman spectroscopy techniques
Raman technique Brief description Advantages Applications in biomedicine
Spontaneous Raman
spectroscopy
Detects intrinsic Raman scattering of
molecules. Can be combined with fibre
probes or microscopy to give spatial and
biochemical information
Label free, non-invasive and non-
destructive, no sample
preparation required
Diagnostics, guided surgery,53, 54 molecular
pathology,82, 83, 97 stem cell
research,24, 65, 67–69, 98 tissue
engineering70–73
RRS Particular bands enhanced by matching the
excitation wavelength with electronic
resonance of molecules, can be coupled with
SERS
103–105-fold increase in signal-
to-noise, chromophores can be
investigated
Characterising specific biomolecules e.g.,
carotenoids, cytochrome25, 26, 99
SERS Raman signal is enhanced using roughened
metal surface e.g., nanoparticles, metal
coated slide
106-fold increase in signal-to-
noise, functionalised
nanoparticles
pH and redox measurements,33, 34 cell-
based assays,100, 101 immunoassays102
SORS Raman signal measured at site offset from
point of excitation, to collect diffusely
scattered photons
Allows greater penetration into
sample, more depth information
in thicker tissues
Potential detection of calcifications and
cancer margins in breast tissue41, 43
SRS/CARS Non-linear variants requiring pulsed,
synchronised laser source.
Video rate, label free
biomolecular imaging, 5×
increase in signal-to-noise
Imaging specific molecules of interest e.g.,
hydroxyapatite, lipids, drugs47, 62, 84
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within patients. Such particles could be detected non-invasively
at depths of 45 mm (refs. 44, 45).
Coherent anti-stokes Raman spectroscopy (CARS) and stimulated
Raman scattering (SRS). While conventional Raman spectroscopy
uses a single continuous laser to generate spectra, CARS and SRS
make use of two pulsed lasers of different wavelengths and are
nonlinear optical processes. The difference between the wave-
lengths is tuned to match a particular vibrational mode of a
molecule of interest, causing an increase in signal intensity
compared to spontaneous Raman scattering. Unlike in sponta-
neous Raman scattering and SRS, the intensity of the CARS signal
is not linearly dependent on the concentration of Raman-active
molecules.46 Molecules at low concentrations can be more difficult
to detect via CARS due to the non-resonant background: a
problem which does not affect SRS. Since they excite a single
vibrational mode (spectral peak), CARS and SRS are most
commonly used in imaging mode, allowing the distribution of
specific chemicals to be measured at video rate.47
Fibre optic probes. As it is a light-based tool, spontaneous Raman
spectroscopy can be combined with optical fibres for endoscopy
of hollow organs such as the lungs, nasopharynx, larynx, trachea,
stomach and colon, providing immense clinical potentialfor in vivo
biomolecular characterisation and diagnosis.48–51 Furthermore,
Raman probes can be fitted with needles for assessment of solid
tissue such as lymph nodes, breast or brain tissue.52 The
combination of Raman with other light-based imaging techniques
(such as autofluorescence) have recently been implemented in the
detection of cancerous cells in biopsies as well as during
surgery.53, 54 The short acquisition times of Raman spectra (less
than 1 s) have allowed internal organs to be assessed accurately,
leading to an objective biomolecular diagnosis in real-time.
Randomised controlled clinical studies are currently underway to
assess the clinical potential of these technologies. For Raman to be
successful, it must complement conventional medical technolo-
gies. Fibre optic Raman spectroscopy may complement conven-
tional medical imaging modalities such as MRI and CT that provide
full body information, but lack the microscopic and biochemical
information that Raman offers.55
Data analysis
For diagnosis to be effective, it must be possible to interpret
spectra unambiguously. Biological samples are complex mixtures
and their Raman spectra contain multiple bands, many of which
overlap and Raman images have further complexity associated
with spatial heterogeneity. When multiple spectra are measured
under different conditions, a multivariate data set is produced—in
addition to the variables of intensity and wavenumber and x, y
coordinates, there can be changes in time, disease state or cell
type. Each variable can be considered as a dimension, so in order
to analyse data, multivariate analysis must be carried out. As
multiple Raman peaks may be affected by a change in conditions,
such multivariate analysis enables the data to be simplified by
reducing the number of dimensions and structuring the data set
in a way that clusters similar spectra and enhances the variance
between different spectra (Fig. 4). One such statistical method is
principal component analysis (PCA), which is used to separate
spectra based on the greatest variance with no a priori knowl-
edge.56 PCA has been used, often in combination with other
Fig. 3 a False colour map of peak due to ring breathing (associated with cytochrome, signal integrated between 740–760 cm−1) in cryosection
of murine liver tissue. Regions of low peak signal intensity are marked in red, while regions of high intensity are marked in yellow. Raman
spectra were acquired with a 532 nm laser at 6 mW power, 3 s exposure and 1 μm resolution using a 50× air objective. False colour scale bar of
signal-to-baseline intensity (arbitrary units) is shown to the right of the map. b Example Raman spectrum from the acquired map
Raman spectroscopy and regenerative medicine
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statistical tools, to discriminate between disease states and cell
types.57, 58
Due to the complexity of biological systems it is challenging to
assign every spectral peak to individual molecular species. While a
comprehensive biological database of Raman spectra is not yet
available, Talari et al.59 have gone some way to achieving this and
have drawn upon a wealth of papers to compile a list of assigned
biologically relevant Raman peaks. As Raman spectroscopy
becomes more common place in biomedical research, one can
anticipate that this list will grow. Chemical information obtained
via destructive analytical techniques such as mass spectrometry
(MS) and nuclear magnetic spectroscopy (NMR) could help assign
Raman peaks associated with normal and diseased states before a
Raman spectroscopic tool is implemented in the clinic.60
APPLICATIONS OF RAMAN SPECTROSCOPY TO REGENERATIVE
MEDICINE
Due to its versatility, Raman spectroscopy could be applied widely
in regenerative medicine and some key areas are highlighted
below.
Raman studies of stem cells and cell lines
Applications of Raman spectroscopy to stem cells. There are
multiple limitations to stem cells for use in research and the clinic
—including heterogeneity in cell populations and uncertainty
surrounding quality of stem cells.61 Non-invasive methods for
determining cell type, detecting apoptotic or disease states and
assessing differentiation would be invaluable to this field of
research and therapy. The capability of Raman spectroscopy to
analyse biomolecular composition renders it promising in all these
respects and it has shown to be suitable for studying numerous
aspects of regeneration.
If undifferentiated stem cells remain among differentiated cells
following therapy, tumours of multiple cell types (teratomas) can
form.62, 63 Currently, stem cells are identified via a number of
methods including destructive immunocytochemical techniques
involving fluorescence,64 but Raman spectroscopy has been used
to separate stem cells and their derivatives. For example, Chan
et al.24 were able to discriminate between human embryonic stem
cells (hESCs) and their cardiomyocyte progeny via multivariate
data analysis of their Raman spectra. Tan et al.65 demonstrated
that spectra of hESCs more closely resemble those of human-
induced pluripotent stem cells than the differentiated progeny of
hESCs. Furthermore, Downes et al.62 have employed CARS
microscopy to image mineralisation in osteoblasts and of lipids
in adipocytes, and discriminate both from adipose-derived stem
cells.
Applications of Raman spectroscopy to cell lines in vitro. Cell lines
are used extensively in regenerative medicine research to
overcome the difficulties of culturing stem cells. However, there
have been problems associated with ascertaining cell quality and
verifying whether the phenotypes of cell lines are indeed similar
to the cells they are used to model. To compare cell lines to
primary stem cells, Swain et al.66 employed single-cell Raman
spectroscopy, revealing that A549 adenocarcinoma cells had a
significantly different biochemical profile to the alveolar type II
(ATII) epithelial cells that they are used to model. Meanwhile, the
alveolar type I-like cell line TT1 provides a reasonably good model
of ATI. This highlights that Raman spectroscopy can be used to
investigate overall biochemical differences between cells rapidly
and non-invasively.
In an effort to quantify cell viability non-invasively, Notingher
et al.67–69 used spontaneous Raman spectroscopy to distinguish
between live and dead cells and also found that the stage of the
cell cycle that particular cells were in could be determined
primarily by changes in peaks attributed to DNA at 782, 788 and
1095 cm−1. Dead cells had particularly low intensity DNA peaks
and also alterations in protein peaks, thought to be due to
changes in protein conformation.
Applications of Raman spectroscopy to tissue engineering
Tissue engineering (TE) has great potential to improve the
outcome for patients with degenerative diseases. The successful
clinical translation of TE as part of a therapy requires the ability to
characterise and quantify tissue formation and compare the TE
implant with native tissue. For instance, in orthopaedic TE such as
cartilage or meniscus, conventional techniques for assessing the
extracellular matrix (ECM) content is based on biochemical assays
and histological staining that are inherently destructive. These
methods remain qualitative or semiquantitative in nature, require
labelling, and are not easily amenable for in-depth analyses of
ECM component distributions. Further, in a translational scheme,
the application of these methods to monitor tissue growth over
time would require the parallel fabrication of sacrificial engineered
tissue samples. Hence, there is a great unmet need to introduce
novel optical techniques such as Raman spectroscopy into TE.
Raman spectroscopy could have an important role in TE both for
biomolecular characterisation and comparisons with native tissues
as well as for quality control of live cell TE formation.
There have been relatively few reports on Raman spectroscopy
for biomolecular assessment of TE constructs. Kunstar et al.70
applied Raman spectroscopy and complementary techniques to
ECM formation in the chondrocyte medium-cultured samples and
in polymeric scaffolds. Khmaladze et al.71 used Raman to detect
spectral changes in thermally stressed tissue 3 weeks post
implantation in mice.
Using Raman microspectroscopy, Gentleman et al.72 studied
mineralised nodules formed in vitro. They found that, although
osteoblasts and adult stem cells exhibited bone-specific biological
activities, the bone nodules formed from embryonic stem cells
lacked the complex biomolecular and mineral composition
observed in the native tissue. Recently, Bergholt et al.73
Fig. 4 Multivariate analysis such as linear discriminant analysis can
be used to separate Raman data into pathologically diagnostic
classes. Here, PC-LDA (principal component linear discriminant
analysis) was used to separate mucosal tissues into three clinically
distinct subsets. Numbers in brackets indicate the number of spectra
in each subset. This methodology allowed correct prediction of
disease states in 93% of measured spectra compared to histopathol-
ogy.96 (Figure reproduced from ref. 96 with permission from Prof. N.
Stone and Journal of Pathology, John Wiley and Sons). LDA, unlike
PCA, does require a priori knowledge of how many subsets of data
are expected. Nevertheless, a way of analysing the data could be
instrumental in accurate diagnoses
Raman spectroscopy and regenerative medicine
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developed a polarised Raman imaging strategy to quantify
the ECM microstructure and biomolecules (i.e., collagen, glycosa-
minoglycans (GAGs) and hydration) of sectioned native articular
cartilage and TE constructs. This technique showed that native
bovine tissues were associated with increased zonal complexity (at
least six distinct zones could be identified) based on collagen
alignment and the biochemical signature. Multivariate curve
resolution (MCR) was used to isolate the pure spectra of
collagen, GAGs and water in both native and tissue engineered
constructs. This enabled them to develop quantitative metrics for
depth-dependent biomolecular comparison between native and
TE constructs.
Raman studies of the regenerative niche
Mechanisms of action of stem cells must often be tailored site-
specifically in order to coordinate an appropriate repair response.
In regenerative medicine, this will prove particularly challenging,
as chronic organ injury is often accompanied by abnormal cellular
signalling and dysregulation of repair pathways which disrupt the
native regenerative niche. Along with its biochemical features, the
physical properties of this supportive niche are critical for effective
stem cell action.2
Physical factors in regeneration—Scaffolds, bone structure and
calcification. Raman spectroscopy can be used to monitor the
hydration of tissues and other structural and physical components
of organs.74, 75 Although regeneration is controlled by biochemical
pathways, there are multiple physical factors which can signifi-
cantly impact the efficiency of regeneration. Structural proteins in
the extracellular environment, cell–cell interactions and the three-
dimensional composition of the tissue can all play critical roles in
repair.76 When such properties are disrupted through disease,
effective regeneration may not be achieved.
Because of this, the tissue–bone interface has long been a
crucial area of interest in regenerative medicine. McManus
et al.77 investigated the differentiation of human mesenchymal
stem cells during the process of bone mineral formation using
Raman spectroscopy with promising results. Changes in Raman
spectra associated with collagen type II formation were
observed before morphological changes—these results were
corroborated by specific staining and RT-PCR (reverse transcrip-
tion polymerase chain reaction). Phosphate peaks also increased
markedly during differentiation, and these could be a marker for
calcification.
In an attempt to assess the molecular alterations associated
with changes in cartilage health upon subchondral bone, Dehring
et al.75 implemented Raman microscopy in the study of murine
knee joints and observed changes in carbonate-phosphate and
mineral-to-matrix ratios in mineral and collagen matrices.
Although such studies often reveal only subtle changes, they
nevertheless illustrate that Raman spectroscopy could be used to
non-invasively assess the properties of bone and tissue scaffolds.
Raman studies of disease states
Metabolomics. Metabolomics is the study of the composition of a
cell or tissue based on its constituent small metabolites. The
concentrations of these molecules are a useful readout of the
developmental and disease state of cells, as many genetic and
biochemical alterations trigger changes in the energy requirement
and production of the cell.56, 78 As small metabolites have
narrower Raman peaks than those due to large molecules such as
proteins, changes in the metabolome could be monitored more
accurately than changes in particular proteins. Additionally,
proteins have very similar Raman spectra to each other (generally
yielding peaks due to amide bonds). Metabolites are more readily
distinguishable; for example adenine and glucose give rise to very
distinct chemical spectra.56
While Raman-based metabolomics is currently in its early days,
it is a field ripe with possibilities. Many diseases are accompanied
by significant changes in concentration in particular metabolites:
diabetes, arthritis and coronary heart disease are associated with
changes in glucose, GAGs and lipids, respectively.79, 80 The
detection of such metabolites in cells or biofluids could greatly
assist the diagnosis of diseases and could be used as a way to
monitor disease progression.
Cancer diagnosis. The uncontrolled proliferation associated with
cancers is akin to aberrant regeneration—cells are permitted to
divide but lack a mechanism to terminate the process.81 Clearly, a
greater understanding of cancer would help researchers better
understand regeneration and vice versa.
Although more accurate diagnosis and improved treatment are
extending the lifespan of patients, the prognosis for many
individuals—for example, those with cholangiocarcinoma and
pancreatic cancer—remains dire. Survival rates for these patients
are impaired by limitations of existing diagnostic techniques, as
well as a lack of tools for defining tumour margins. Poor definition
of tumour boundaries can lead to incomplete excision of
cancerous tissue or unnecessary removal of healthy tissue.
Observations that there are differences in Raman spectra between
tumour and non-tumour areas of tissue has led to the technique
being applied to study of a multiplicity of cancers.23, 32, 41, 82–87
Lung, breast, brain and oesophageal cancers all exhibit distinct
changes in their Raman spectral profiles compared to normal
tissue.44, 48, 88, 89 Much progress has been made in the definition
of brain tumour margins.84 Jermyn et al.54 have developed a hand-
held fibre-optic Raman probe capable of detecting diffusely
invasive brain cancer cells in real time during surgery, and it is
currently in use in clinics. The initial device employed a 785 nm
excitation laser and could differentiate between normal and
cancerous tissue with a sensitivity of 93% and a specificity of 91%
—significantly better than current surgical techniques.
To specifically probe changes in lipid concentrations during
disease, the CARS technique can be used. Initial experiments have
shown that CARS is able to differentiate between healthy brain
tissue and glioblastomas induced in mice models, based on the
lower lipid content of brain tumours.84 Localised lipid concentra-
tions play an important role in many diseases which CARS could
be used to investigate, including heart diseases and neuropathies
such as multiple sclerosis.81
PRACTICAL ASPECTS OF RAMAN SPECTROSCOPY
Raman spectroscopy offers a number of advantages over other
analytical methods for the study of biological systems; however,
there are a number of practical limitations that could restrict its
use in some systems. Here, we list a number of factors that should
be taken into consideration when selecting a bioanalytical tool,
and highlight both advantages and disadvantages of Raman
spectroscopy (summarised in Fig. 5).
Sample
As Raman scattering is intrinsic to most biomolecules and is not
affected by the presence of water, very little sample preparation is
required when carrying out spontaneous Raman spectroscopy.20 A
wide variety of specimens can be investigated; these include
whole organs, tissue sections, cell culture and biological fluids e.g.,
serum, saliva and blood. For collection of high quality spectra from
sections or two-dimensional culture, the preferred substrates are
slides made of quartz, magnesium fluoride and calcium fluoride,
as they have low intrinsic Raman or fluorescence signal and are
commercially available.90 Glass slides are fluorescent across a wide
wavenumber range, producing a broad signal which overlaps with
Raman signals, so should be avoided.20 Very recently state-of-the-
Raman spectroscopy and regenerative medicine
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art confocal Raman systems have enabled Raman imaging of cells
on conventional glass slides without interference.91
Since Raman spectroscopy analyses the chemical composition
of biological samples, chemical processes such as fixation or
deparaffinisation could alter the sample and thus the spectrum.20
Therefore, unfixed frozen tissue samples are preferable to
formalin-, methanol- or paraffin-fixed samples. Such frozen
samples can be thawed at room temperature prior to analysis.92
Instrumentation. The miniaturisation of electronics and laser
sources has led to the rise of handheld Raman technology.
Multiple companies have developed portable Raman devices for
detecting explosives, pharmaceutical drug analysis and raw
material identification, with the smallest handheld spectrometers
weighing less than 1 kg (ref. 93). Such cheap and transportable
devices have many potential clinical applications and may be
useful in diagnosis or assessment of regeneration in vivo.
Laser wavelength and power must be carefully selected to suit
the particular study because the intensity of Raman scattering is
greater at short wavelengths and for resonance Raman the laser
should be chosen to match an electronic transition.94 However,
since UV–Visible lasers have associated phototoxicity, 785 nm and
1064 nm lasers are the wavelengths most commonly applied to
biological systems.21
Quantitation
As the intensity of Raman scattering is directly proportional to the
concentration of molecules in transparent samples, Raman
spectroscopy can be used in a quantitative manner for cells and
solutions. Enejder et al.95 used the correlation between molecular
concentration and Raman scattering concept to develop a
method for non-invasively monitoring blood glucose
concentrations.
Acquisition speed
Acquisition of a single Raman spectrum can take less than a
second, and although mapping of large areas with high resolution
is time-consuming, random sampling and averaging of spectra
where appropriate can allow the chemical composition of a
sample to be approximated. Raman can, therefore, be applied
in vivo and can be used to look at disease states over time, or the
response of cells to drugs, changes in pH or other external
conditions.47, 55 Slit scanning technology enables faster imaging:
laser light is spread over a line rather than focussed on a single
point, enabling multiple spectra to be acquired rapidly and
reducing overall acquisition time. Such a technique could be used
to diagnose diseases from biopsies via “spectral histopathology”.
SUMMARY
In summary, Raman spectroscopy is a non-invasive, non-
destructive technique for analysing molecular composition that
can be applied to a plethora of sample types. As the field of
regenerative medicine makes use of a wide variety of samples—
cell lines, stem cells, scaffolds, human tissues and animal models
—with the end goal of developing treatments for use in human
patients, the versatility of Raman renders it an ideal tool for
biomolecular analysis.
In the field of regenerative medicine, where our focus should be
on implementing novel therapeutic and diagnostic techniques in
humans and monitoring the effects of therapy non-invasively—a
label-free method of discriminating between samples based on
their molecular composition would benefit the field enormously.
Although initial studies show that Raman has many promising
applications to regenerative medicine, these investigations
primarily constitute in vitro work. To develop the full potential
of Raman, cross-talk between physicists and chemists developing
new Raman technology and biologists and clinicians working in
the field, would enable Raman spectroscopy to address many
unmet needs in the field of regenerative medicine (summarised in
Fig. 6).
It would undoubtedly be beneficial for faculties carrying out
research into regeneration to have access to a Raman system. The
imaging modality and rapid acquisition times of Raman spectro-
scopy will allow researchers to monitor the distribution of
biochemicals over time, while its quantitative nature could enable
local chemical concentrations to be determined. Such information
would facilitate discrimination between different cell and tissue
types, allowing non-invasive monitoring of cell viability, differentia-
tion and disease states. Thus, implementation of Raman spectro-
scopy would deepen our understanding of the fundamental nature
of regeneration.
Raman spectroscopy could additionally be incorporated as a
quality control tool. For example, it could be used to ascertain
whether artificial organs and tissue scaffolds reflect human organs
biochemically and thus whether they are likely to fulfil the
required functions, and whether donor organs are suitable for
transplantation. Here, the non-destructive nature of the spectro-
scopic tool would be key as such resources are extremely valuable
and their quality is critical to their function.
Fig. 5 Advantages and disadvantages of Raman spectroscopy
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It should be highlighted that Raman spectroscopy will not
necessarily supplant other techniques; rather its future lies in
complimenting the well-established methods and shedding new
light on the biochemical state in vivo. NMR and MS can provide
greater chemical resolution than Raman but are both destructive
techniques that require extensive sample preparation. Although
Raman has not yet achieved full imaging capability in the clinic,
the instrumentation is inexpensive and compact, and radioactive
tracers are not required to aid diagnosis.
The true value of Raman unquestionably lies in its versatility and
non-destructive nature—it can generate molecular information
about in vitro and in vivo samples, and has been applied
successfully in primary research and in a clinical setting. An
analytical technique that is able to transcend boundaries in such a
manner would be invaluable for the field of regenerative
medicine, where transferring knowledge from the bench to the
bedside is critical for progress.
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